eNeuro,
Journal Year:
2023,
Volume and Issue:
10(12), P. ENEURO.0367 - 23.2023
Published: Dec. 1, 2023
Dysfunction
in
the
gene
SCN2A,
which
encodes
voltage-gated
sodium
channel
Nav1.2,
is
strongly
associated
with
neurodevelopmental
disorders
including
autism
spectrum
disorder
and
intellectual
disability
(ASD/ID).
This
dysfunction
typically
manifests
these
as
a
haploinsufficiency,
where
loss
of
one
copy
cannot
be
compensated
for
by
other
allele.
Scn2a
haploinsufficiency
affects
range
cells
circuits
across
brain,
associative
neocortical
that
are
important
cognitive
flexibility
decision-making
behaviors.
Here,
we
tested
whether
has
any
effect
on
dynamic
foraging
task
engages
such
circuits.
+/-
mice
wild-type
(WT)
littermates
were
trained
choice
behavior
probability
reward
between
two
options
varied
dynamically
trials
location
high
underwent
uncued
reversals.
Despite
impairments
Scn2a-related
neuronal
excitability,
found
both
male
female
performed
tasks
well
littermates,
no
behavioral
difference
genotypes
learning
or
performance
parameters.
Varying
number
reversals
probabilities
receiving
did
not
result
an
observable
difference,
either.
These
data
suggest
that,
despite
heterozygous
Scn2a,
can
perform
relatively
complex
make
use
higher-order
Autism Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Autism
spectrum
disorder
(ASD)
is
a
complex
neuro
developmental
condition
characterized
by
significant
genetic
and
phenotypic
variability,
making
diagnosis
treatment
challenging.
The
heterogeneity
of
ASD-associated
variants
the
absence
clear
causal
factors
in
many
cases
complicate
personalized
care.
Traditional
models,
such
as
postmortem
brain
tissue
animal
studies,
have
provided
valuable
insights
but
are
limited
capturing
dynamic
processes
human-specific
aspects
ASD
pathology.
Recent
advances
human
induced
pluripotent
stem
cell
(iPSC)
technology
transformed
research
enabling
generation
patient-derived
neural
cells
both
two-dimensional
cultures
three-dimensional
organoid
models.
These
models
retain
donor's
background,
allowing
researchers
to
investigate
disease-specific
cellular
molecular
mechanisms
while
identifying
potential
therapeutic
targets
tailored
individual
patients.
This
commentary
highlights
how
cell-based
approaches
advancing
our
understanding
paving
way
for
more
diagnostic
strategies.
Journal of Child and Adolescent Psychopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Objectives:
Despite
growing
knowledge
of
the
underlying
neurobiology
autism
spectrum
disorder
(ASD)
and
related
neurogenetic
syndromes,
treatment
discovery
has
remained
elusive.
In
this
review,
we
provide
a
blueprint
for
translational
precision
medicine
in
ASD
syndromes.
Methods:
The
trofinetide
Rett
syndrome
(RTT)
is
described,
role
nonmammalian,
mammalian,
stem
cell
model
systems
identification
molecular
targets
drug
screening
discussed.
We
then
framework
translating
preclinical
findings
to
human
clinical
trials,
including
biomarkers
selecting
evaluating
target
engagement,
discuss
how
leverage
these
future
development.
Results:
Multiple
have
been
developed,
each
with
tradeoffs
regard
suitability
high-throughput
small
molecule
screening,
conservation
across
species,
behavioral
face
validity.
Future
trials
should
incorporate
intermediate
phenotypes
demonstrate
engagement.
Factors
that
contributed
approval
RTT
included
replicated
mouse
models,
well-studied
natural
history
syndrome,
development
RTT-specific
outcome
measures,
strong
engagement
family
community.
Conclusions:
translation
our
understanding
will
require
approach,
use
multiple
selection,
evaluation
trial
design
strategies
address
heterogeneity,
power,
placebo
response.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 28, 2024
Abstract
Autism
spectrum
disorder
(ASD)
is
a
neurodevelopmental
characterized
by
complex
sensory
processing
deficits.
A
key
unresolved
question
how
alterations
in
neural
connectivity
and
communication
translate
into
the
behavioral
manifestations
seen
ASD.
Here,
we
investigate
oligodendrocyte
dysfunction
alters
myelin
plasticity
neuronal
activity,
leading
to
auditory
associated
with
We
focus
on
SCN2A
gene,
an
ASD-risk
factor,
understand
its
role
myelination
within
nervous
system.
Through
transcriptional
profiling,
identified
expression
of
myelin-associated
genes
Scn2a
conditional
knockout
mice,
highlighting
cellular
consequences
engendered
deletion
oligodendrocytes.
The
results
reveal
nuanced
interplay
between
oligodendrocytes
axons,
where
causes
intricate
process
myelination.
This
disruption
instigates
changes
axonal
properties,
presynaptic
excitability,
synaptic
at
single
cell
level.
Furthermore,
oligodendrocyte-specific
compromises
integrity
circuitry
pathways,
hypersensitivity.
Our
findings
novel
pathway
linking
deficits
activity
abnormalities
The
signaling
complex
around
voltage-gated
sodium
(Nav)
channels
includes
accessory
proteins
and
kinases
crucial
for
regulating
neuronal
firing.
Previous
studies
showed
that
one
such
kinase,
WEE1—critical
to
the
cell
cycle—selectively
modulates
Nav1.2
channel
activity
through
protein
fibroblast
growth
factor
14
(FGF14).
Here,
we
tested
whether
WEE1
exhibits
crosstalk
with
AKT/GSK3
pathway
coordinated
regulation
of
FGF14/Nav1.2
assembly
function.
Using
in-cell
split
luciferase
complementation
assay
(LCA),
found
inhibitor
II
GSK3
XIII
reduce
formation,
while
AKT
triciribine
increases
it.
However,
combining
either
other
two
inhibitors
abolished
its
effect
on
formation.
Whole-cell
voltage-clamp
recordings
currents
(INa)
in
HEK293
cells
co-expressing
FGF14-GFP
significantly
suppresses
peak
INa
density,
both
alone
presence
or
XIII,
despite
latter
inhibitors’
opposite
effects
INa.
Additionally,
slowed
tau
fast
inactivation,
caused
depolarizing
shifts
voltage
dependence
activation
inactivation.
These
phenotypes
prevailed
were
additive
when
combined
but
outcompeted
present.
Concerted
by
II,
also
observed
long-term
inactivation
use-dependence
currents.
Overall,
these
findings
suggest
a
role
kinase—in
concert
pathway—in
channelosome.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 11, 2024
Abstract
Cerebellar
dysfunction
leads
to
motor,
learning,
emotional,
and
social
deficits.
It
is
assumed
that
these
deficits
arise
from
impaired
processing
of
mossy
fiber
inputs
activate
granule
cells
(GCs)
in
turn
excite
Purkinje
(PCs).
However,
high-frequency
spontaneous
PC
firing
might
also
influence
behaviors.
To
clarify
how
the
cerebellum
regulates
behaviors,
we
compared
effects
disrupting
either
GC
signaling,
which
selectively
perturbs
cerebellar
processing,
or
disrupts
firing.
We
find
both
signaling
are
required
for
eyeblink
conditioning
vestibulo-ocular
reflex
(VOR)
learning.
impairs
baseline
VOR,
anxiety,
but
abolishing
does
not.
This
establishes
essential
motor
not
many
cerebellum-dependent
suggests
such
behaviors
could
be
rescued
by
elevating
downstream
targets,
as
shown
previously
Therapeutic Advances in Rare Disease,
Journal Year:
2024,
Volume and Issue:
5
Published: Jan. 1, 2024
The
SCN2A
gene
encodes
the
Nav1.2
protein,
a
voltage-gated
sodium
channel
crucial
for
initiating
and
transmitting
action
potentials
in
neurons.
Dysfunction
Nav1.2,
often
stemming
from
genetic
mutations
gene,
leads
to
SCN2A-related
disorders.
Individuals
harboring
pathogenic
variants
present
with
severe
neurodevelopmental
disorders
such
as
epilepsy,
autism
spectrum
disorders,
movement
cortical
visual
impairment,
intellectual
disabilities.
FamilieSCN2A
Foundation,
501(c)(3)
patient
advocacy
organization,
is
dedicated
enhancing
lives
of
those
affected
by
Fueled
vision
world
effective
treatments
cures
all
patients
Foundation
has
charted
course
cure
based
on
their
core
values
urgency,
integrity,
collaboration,
inclusion.
Their
strategic
plan
centers
building
comprehensive
research-readiness
infrastructure
that
maximizes
probability
bringing
curative
therapies
patients.
Appreciating
statistically
most
drug
development
initiatives
will
fail,
creating
an
number
drugs
turn
net
success
achieving
vision.
Through
dynamic
notable
achievements,
including
raising
~$6
million
USD,
funding
26
research
grants
totaling
~$4.7
forging
partnerships
across
disorder
ecosystem
foundation
actively
executing
its
plan.
With
advancing
rapidly
thriving
diverse,
engaged
stakeholders,
believes
outlook
bright.
Cambridge University Press eBooks,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 22, 2024
SCN2A
encodes
a
voltage-gated
sodium
channel
(designated
NaV1.2)
vital
for
generating
neuronal
action
potentials.
Pathogenic
variants
are
associated
with
diverse
array
of
neurodevelopmental
disorders
featuring
neonatal
or
infantile
onset
epilepsy,
developmental
delay,
autism,
intellectual
disability
and
movement
disorders.
is
high
confidence
risk
gene
autism
spectrum
disorder
commonly
discovered
cause
epilepsy.
This
remarkable
clinical
heterogeneity
mirrored
by
extensive
allelic
complex
genotype-phenotype
relationships
partially
explained
divergent
functional
consequences
pathogenic
variants.
Emerging
therapeutic
strategies
targeted
to
specific
patterns
NaV1.2
dysfunction
offer
hope
improving
the
lives
individuals
affected
SCN2A-related
Element
provides
review
features,
genetic
basis,
pathophysiology,
pharmacology
treatment
these
conditions
authored
leading
experts
in
field
accompanied
perspectives
shared
families.
title
also
available
as
Open
Access
on
Cambridge
Core.